Yu Aoki

434 total citations
32 papers, 291 citations indexed

About

Yu Aoki is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Yu Aoki has authored 32 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Yu Aoki's work include Gastrointestinal Tumor Research and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Yu Aoki is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Yu Aoki collaborates with scholars based in Japan and United States. Yu Aoki's co-authors include Akihiko Takeuchi, Hiroyuki Tsuchiya, Takashi Higuchi, Katsuhiro Hayashi, Norio Yamamoto, Shinji Miwa, Hiroyuki Inatani, Katsunori Yogo, Yasunori Oumi and Shigeyuki Uemiya and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Nutrients.

In The Last Decade

Yu Aoki

31 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Aoki Japan 11 79 71 68 42 39 32 291
Yanjun Liu China 14 42 0.5× 112 1.6× 178 2.6× 65 1.5× 18 0.5× 54 438
Xue Fan China 12 62 0.8× 45 0.6× 151 2.2× 61 1.5× 21 0.5× 42 390
Daisuke Kajiwara Japan 8 109 1.4× 61 0.9× 45 0.7× 20 0.5× 12 0.3× 22 368
Siying He China 13 27 0.3× 69 1.0× 238 3.5× 29 0.7× 22 0.6× 30 445
Jae Yeon Jung United States 10 76 1.0× 113 1.6× 32 0.5× 71 1.7× 9 0.2× 26 306
Yongwei Hu China 13 66 0.8× 27 0.4× 188 2.8× 107 2.5× 23 0.6× 32 435
Jianfeng Zheng China 10 47 0.6× 57 0.8× 92 1.4× 67 1.6× 4 0.1× 37 402
Shinichiro Suzuki Japan 11 95 1.2× 54 0.8× 114 1.7× 105 2.5× 9 0.2× 54 377
Sung Kyung Cho United States 10 57 0.7× 114 1.6× 100 1.5× 14 0.3× 8 0.2× 21 424

Countries citing papers authored by Yu Aoki

Since Specialization
Citations

This map shows the geographic impact of Yu Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Aoki more than expected).

Fields of papers citing papers by Yu Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Aoki. The network helps show where Yu Aoki may publish in the future.

Co-authorship network of co-authors of Yu Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Aoki. A scholar is included among the top collaborators of Yu Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Aoki. Yu Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aoki, Yu, Tadayoshi Hashimoto, Nobuyuki Takahashi, et al.. (2025). Clinical Significance of Extrachromosomal DNA in FGFR2 -Amplified Gastric Cancer: Therapeutic Implications From Clinical Experience. JCO Precision Oncology. 9(9). e2500033–e2500033.
2.
Aoki, Yu, Izuma Nakayama, & Kohei Shitara. (2025). Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights. Current Oncology Reports. 27(1). 15–29. 1 indexed citations
5.
Furukawa, Masae, et al.. (2023). Erythritol Can Inhibit the Expression of Senescence Molecules in Mouse Gingival Tissues and Human Gingival Fibroblasts. Nutrients. 15(18). 4050–4050. 4 indexed citations
6.
Kubota, Yohei, Yu Aoki, Akihito Kawazoe, & Kohei Shitara. (2022). Role of Nivolumab in the Management of First-Line Unresectable Advanced or Recurrent Gastric Cancer in Combination with Chemotherapy: Lessons from the Japanese Experience. Cancer Management and Research. Volume 14. 3083–3094. 4 indexed citations
7.
Aoki, Yu, Akihito Kawazoe, Yohei Kubota, et al.. (2022). Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors. International Journal of Clinical Oncology. 27(9). 1413–1420. 3 indexed citations
8.
Takeuchi, Masashi, Chiyo K. Imamura, Eisuke Booka, et al.. (2020). Prospective evaluation and refinement of an S‐1 dosage formula based on renal function for clinical application. Cancer Science. 112(2). 751–759. 3 indexed citations
9.
Aoki, Yu, Daisuke Hagiwara, Teruo Kuroda, et al.. (2020). Genome Mining-Based Discovery of Fungal Macrolides Modified by glycosylphosphatidylinositol (GPI)–Ethanolamine Phosphate Transferase Homologues. Organic Letters. 22(15). 5876–5879. 23 indexed citations
10.
Abe, Kensaku, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2019). Satisfaction After Joint-preservation Surgery in Patients With Musculoskeletal Knee Sarcoma Based on Various Scores. Anticancer Research. 39(4). 1959–1964. 3 indexed citations
11.
Abe, Kensaku, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2019). Determining Patient Satisfaction and Treatment Desires in Patients With Musculoskeletal Sarcoma of the Knee After Joint-preservation Surgery Using a Questionnaire Survey. Anticancer Research. 39(4). 1965–1969. 4 indexed citations
12.
13.
Kasuga, Akiyoshi, Yasuo Hamamoto, Ayano Takeuchi, et al.. (2018). Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis. Investigational New Drugs. 36(5). 939–948. 6 indexed citations
14.
Higuchi, Takashi, Norio Yamamoto, Hideji Nishida, et al.. (2017). Knee joint preservation surgery in osteosarcoma using tumour-bearing bone treated with liquid nitrogen. International Orthopaedics. 41(10). 2189–2197. 18 indexed citations
15.
Hamamoto, Yasuo, Masanori Nojima, Yu Aoki, et al.. (2017). Inter-evaluator heterogeneity of clinical diagnosis for locally advanced esophageal squamous cell carcinoma. Esophagus. 14(4). 324–332. 11 indexed citations
16.
Abe, Kensaku, Akihiko Takeuchi, Norio Yamamoto, et al.. (2015). Symptomatic small schwannoma is a risk factor for surgical complications and correlates with difficulty of enucleation. SpringerPlus. 4(1). 751–751. 13 indexed citations
18.
Morita, Hiroshi, Yu Aoki, Shigeru Takahara, & Masanobu Wakasa. (2010). Fluorescent Spherical Particle Formation from Solid Polysilanes by the Aid of Laser Ablation and Photochemical Reaction. Journal of Photopolymer Science and Technology. 23(3). 371–378. 2 indexed citations
19.
Matsuura, Hiroyuki, et al.. (1993). Dilation of the ductus arteriosus by oral prostaglandin E1 derivative in cyanotic congenital heart diseases. American Heart Journal. 125(5). 1453–1454. 3 indexed citations
20.
Sato, Toshiya, et al.. (1965). [Clinical trials with ethosuximide (Zarontin) in therapy-resistant epileptics].. PubMed. 17(9). 958–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026